Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.

Mari R, Mamessier E, Lambaudie E, Provansal M, Birnbaum D, Bertucci F, Sabatier R

Open source

DOI
10.3390/cancers11060774
Published
2019 Jun 4
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers11060774,
  title = {Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.},
  author = {Mari R and Mamessier E and Lambaudie E and Provansal M and Birnbaum D and Bertucci F and Sabatier R},
  year = {2019},
  journal = {Cancers},
  doi = {10.3390/cancers11060774},
  url = {https://doi.org/10.3390/cancers11060774}
}

RIS

TY  - JOUR
TI  - Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.
AU  - Mari R
AU  - Mamessier E
AU  - Lambaudie E
AU  - Provansal M
AU  - Birnbaum D
AU  - Bertucci F
AU  - Sabatier R
PY  - 2019
JO  - Cancers
DO  - 10.3390/cancers11060774
UR  - https://doi.org/10.3390/cancers11060774
ER  - 

APA

R, M., E, M., E, L., M, P., D, B., F, B., & R, S. (2019). Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.. Cancers. https://doi.org/10.3390/cancers11060774

Source records